DE602004006566D1 - Verfahren zur Diagnose und Behandlung von Metastasen und dafür nützliche Zusammensetzung - Google Patents

Verfahren zur Diagnose und Behandlung von Metastasen und dafür nützliche Zusammensetzung

Info

Publication number
DE602004006566D1
DE602004006566D1 DE602004006566T DE602004006566T DE602004006566D1 DE 602004006566 D1 DE602004006566 D1 DE 602004006566D1 DE 602004006566 T DE602004006566 T DE 602004006566T DE 602004006566 T DE602004006566 T DE 602004006566T DE 602004006566 D1 DE602004006566 D1 DE 602004006566D1
Authority
DE
Germany
Prior art keywords
diagnosis
treatment
metastases
composition useful
useful therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004006566T
Other languages
English (en)
Other versions
DE602004006566T2 (de
Inventor
Marie-Christine Rio
Ulrich Weidle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE602004006566D1 publication Critical patent/DE602004006566D1/de
Application granted granted Critical
Publication of DE602004006566T2 publication Critical patent/DE602004006566T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004006566T 2003-07-28 2004-07-28 Verfahren zur Diagnose und Behandlung von Metastasen und dafür nützliche Zusammensetzung Active DE602004006566T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03016586 2003-07-28
EP03016586 2003-07-28

Publications (2)

Publication Number Publication Date
DE602004006566D1 true DE602004006566D1 (de) 2007-07-05
DE602004006566T2 DE602004006566T2 (de) 2008-01-24

Family

ID=34089578

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004006566T Active DE602004006566T2 (de) 2003-07-28 2004-07-28 Verfahren zur Diagnose und Behandlung von Metastasen und dafür nützliche Zusammensetzung

Country Status (7)

Country Link
US (1) US20050032101A1 (de)
JP (1) JP4113167B2 (de)
CN (2) CN101649351A (de)
AT (1) ATE363075T1 (de)
CA (1) CA2469094A1 (de)
DE (1) DE602004006566T2 (de)
ES (1) ES2286539T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114933646A (zh) * 2022-06-22 2022-08-23 南通市第一老年病医院(上海大学附属南通医院、南通市第六人民医院、南通市肺科医院) Smagp蛋白多肽构建及其抗脂肪性肝病活性的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974667B2 (en) * 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
US6448041B1 (en) * 2000-12-18 2002-09-10 Incyte Genomics, Inc. Colon cancer marker

Also Published As

Publication number Publication date
ATE363075T1 (de) 2007-06-15
US20050032101A1 (en) 2005-02-10
JP2005130848A (ja) 2005-05-26
ES2286539T3 (es) 2007-12-01
DE602004006566T2 (de) 2008-01-24
CN100541198C (zh) 2009-09-16
CN101649351A (zh) 2010-02-17
JP4113167B2 (ja) 2008-07-09
CN1576840A (zh) 2005-02-09
CA2469094A1 (en) 2005-01-28

Similar Documents

Publication Publication Date Title
ATE443260T1 (de) Kontrastmittel und verfahren zum imaging von naaldase oder psma
ATE516042T1 (de) Zusammensetzungen und verfahren zur behandlung und diagnose von tumoren
ATE522623T1 (de) Zusammensetzungen und verfahren zur behandlung und diagnose von lungentumoren
ATE493433T1 (de) Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen
ATE453653T1 (de) Platinkomplexe zur behandlung von tumoren
ATE455463T1 (de) Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
TW200626899A (en) Frizzled proteins and detection and treatment of cancer
ATE464323T1 (de) Zusammensetzungen und verfahren für die tumor- diagnose und behandlung
TW200626900A (en) Wnt proteins and detection and treatment of cancer
DE602004016499D1 (de) Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
NO20055741D0 (no) Nye kjemiske forbindelser
DE602006009786D1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE494296T1 (de) Zusammensetzungen und verfahren für die tumordiagnose und behandlung
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
ATE480641T1 (de) Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes
ATE476982T1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
DE602005013287D1 (de) Zusammensetzung zur behandlung von leder
DE60024997D1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
DE602005027228D1 (de) Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind
ATE375389T1 (de) Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen
DE602004006566D1 (de) Verfahren zur Diagnose und Behandlung von Metastasen und dafür nützliche Zusammensetzung
DE60144493D1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
ATE414539T1 (de) Verfahren und materialien zur behandlung und diagnose von mit kallikrein-6 zusammenhängenden entzündlichen zuständen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition